{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:23:41Z","timestamp":1785896621326,"version":"3.56.0"},"reference-count":55,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/or.2012.2164","type":"journal-article","created":{"date-parts":[[2012,12,3]],"date-time":"2012-12-03T11:09:08Z","timestamp":1354532948000},"page":"563-570","source":"Crossref","is-referenced-by-count":21,"title":["The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas"],"prefix":"10.3892","volume":"29","author":[{"given":"GU","family":"LI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KIRSTEN","family":"HATTERMANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROLF","family":"MENTLEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. MAXIMILIAN","family":"MEHDORN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JANKA","family":"HELD-FEINDT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,12,3]]},"reference":[{"key":"key20180107214329_b1-or-29-02-0563","first-page":"176","article-title":"Meningiomas","volume-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Nervous System","author":"Louis","year":"2000"},{"key":"key20180107214329_b2-or-29-02-0563","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol"},{"key":"key20180107214329_b3-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","article-title":"Meningiomas","volume":"363","author":"Whittle","year":"2004","journal-title":"Lancet"},{"key":"key20180107214329_b4-or-29-02-0563","first-page":"83","article-title":"Current management of meningiomas","volume":"9","author":"De Monte","year":"1995","journal-title":"Oncology"},{"key":"key20180107214329_b5-or-29-02-0563","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","article-title":"The recurrence of intracranial meningiomas after surgical treatment","volume":"20","author":"Simpson","year":"1957","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20180107214329_b6-or-29-02-0563","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3171\/jns.1998.88.5.0831","article-title":"Factors associated with survival in patients with meningioma","volume":"88","author":"McCarthy","year":"1998","journal-title":"J Neurosurg"},{"key":"key20180107214329_b7-or-29-02-0563","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/FOC-07\/10\/E4","article-title":"Role of radiation therapy in treating intracranial meningiomas","volume":"23","author":"Rogers","year":"2007","journal-title":"Neurosurg Focus"},{"key":"key20180107214329_b8-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1471-4159.2002.01091.x","article-title":"Characterization of chemokines and their receptors in the central nervous system: physiopathological implications","volume":"82","author":"Bajetto","year":"2002","journal-title":"J Neurochem"},{"key":"key20180107214329_b9-or-29-02-0563","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","article-title":"CXCL12(SDF-1)\/CXCR4 pathway in cancer","volume":"16","author":"Teicher","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107214329_b10-or-29-02-0563","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/pr.54.2.227","article-title":"International Union of Pharmacology. XXX Update on chemokine receptor nomenclature","volume":"54","author":"Murphy","year":"2002","journal-title":"Pharmacol Rev"},{"key":"key20180107214329_b11-or-29-02-0563","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.21301","article-title":"Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis","volume":"52","author":"Nanki","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key20180107214329_b12-or-29-02-0563","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.atherosclerosis.2007.11.034","article-title":"CXCL16\/SR-PSOX - a friend or a foe in atherosclerosis?","volume":"197","author":"Sheikine","year":"2008","journal-title":"Atherosclerosis"},{"key":"key20180107214329_b13-or-29-02-0563","first-page":"65","article-title":"Expression of CXCL16 in human rectal cancer","volume":"14","author":"W\u00e5gs\u00e4ter","year":"2004","journal-title":"Int J Mol Med"},{"key":"key20180107214329_b14-or-29-02-0563","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1386207053258488","article-title":"Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules","volume":"8","author":"Ludwig","year":"2005","journal-title":"Comb Chem High Throughput Screen"},{"key":"key20180107214329_b15-or-29-02-0563","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/glia.20651","article-title":"Overexpression of CXCL16 and its receptor CXCR6\/Bonzo promotes growth of human schwannomas","volume":"56","author":"Held-Feindt","year":"2008","journal-title":"Glia"},{"key":"key20180107214329_b16-or-29-02-0563","doi-asserted-by":"crossref","first-page":"e6695","DOI":"10.1371\/journal.pone.0006695","article-title":"The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers","volume":"4","author":"Darash-Yahana","year":"2009","journal-title":"PLoS One"},{"key":"key20180107214329_b17-or-29-02-0563","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2008.04.024","article-title":"Glial cross-talk by transmembrane chemokines CX3CL1 and CXCL16","volume":"198","author":"Ludwig","year":"2008","journal-title":"J Neuroimmunol"},{"key":"key20180107214329_b18-or-29-02-0563","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.4049\/jimmunol.172.10.6362","article-title":"The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10","volume":"172","author":"Abel","year":"2004","journal-title":"J Immunol"},{"key":"key20180107214329_b19-or-29-02-0563","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2008.04.016","article-title":"CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes","volume":"198","author":"Liu","year":"2008","journal-title":"J Neuroimmunol"},{"key":"key20180107214329_b20-or-29-02-0563","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor","volume":"9","author":"Cardona","year":"2006","journal-title":"Nat Neurosci"},{"key":"key20180107214329_b21-or-29-02-0563","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1158\/0008-5472.CAN-06-3424","article-title":"High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer","volume":"67","author":"Hojo","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107214329_b22-or-29-02-0563","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejca.2008.10.023","article-title":"Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients","volume":"45","author":"Gutwein","year":"2009","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"key20180107214329_b23-or-29-02-0563","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1245\/s10434-011-1993-8","article-title":"Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients","volume":"19","author":"Matsushita","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"key20180107214329_b24-or-29-02-0563","first-page":"419","article-title":"Clinical significance of CXCL16\/CXCR6 expression in patients with prostate cancer","volume":"4","author":"Ha","year":"2011","journal-title":"Mol Med Rep"},{"key":"key20180107214329_b25-or-29-02-0563","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mcn.2008.03.009","article-title":"The chemokine CXCL16 induces migration and invasion of glial precursor cells via its receptor CXCR6","volume":"39","author":"Hattermann","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"key20180107214329_b26-or-29-02-0563","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuint.2006.03.003","article-title":"Expression of CXC chemokine receptors 1\u20135 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration","volume":"49","author":"Bajetto","year":"2006","journal-title":"Neurochem Int"},{"key":"key20180107214329_b27-or-29-02-0563","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1200\/JCO.2008.17.2833","article-title":"Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma","volume":"26","author":"Rodero","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107214329_b28-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/eji.200526042","article-title":"Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells","volume":"35","author":"Xin","year":"2005","journal-title":"Eur J Immunol"},{"key":"key20180107214329_b29-or-29-02-0563","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ijc.22660","article-title":"Defective antitumor response in CX3CR1-deficient mice","volume":"121","author":"Yu","year":"2007","journal-title":"Int J Cancer"},{"key":"key20180107214329_b30-or-29-02-0563","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(00)80438-9","article-title":"Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion","volume":"91","author":"Imai","year":"1997","journal-title":"Cell"},{"key":"key20180107214329_b31-or-29-02-0563","doi-asserted-by":"crossref","first-page":"23799","DOI":"10.1074\/jbc.273.37.23799","article-title":"Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1","volume":"273","author":"Combadiere","year":"1998","journal-title":"J Biol Chem"},{"key":"key20180107214329_b32-or-29-02-0563","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH07-01-0035","article-title":"Transmembrane chemokines: versatile \u2018special agents\u2019 in vascular inflammation","volume":"97","author":"Ludwig","year":"2007","journal-title":"Thromb Haemost"},{"key":"key20180107214329_b33-or-29-02-0563","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.4049\/jimmunol.165.6.3284","article-title":"The primate lentiviral receptor Bonzo\/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse","volume":"165","author":"Unutmaz","year":"2000","journal-title":"J Immunol"},{"key":"key20180107214329_b34-or-29-02-0563","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/79738","article-title":"A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo","volume":"1","author":"Matloubian","year":"2000","journal-title":"Nat Immunol"},{"key":"key20180107214329_b35-or-29-02-0563","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1371\/journal.pbio.0030113","article-title":"Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids","volume":"3","author":"Geissmann","year":"2005","journal-title":"PLoS Biol"},{"key":"key20180107214329_b36-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1471-4159.2006.04276.x","article-title":"Overexpression of midkine contributes to anti-apoptotic effects in human meningiomas","volume":"100","author":"Tong","year":"2007","journal-title":"J Neurochem"},{"key":"key20180107214329_b37-or-29-02-0563","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nri748","article-title":"Chemokines: agents for the immunotherapy of cancer?","volume":"2","author":"Homey","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"key20180107214329_b38-or-29-02-0563","doi-asserted-by":"crossref","first-page":"10896","DOI":"10.1073\/pnas.95.18.10896","article-title":"Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia","volume":"95","author":"Harrison","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107214329_b39-or-29-02-0563","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jnr.10304","article-title":"Fractalkine and fractalkine receptors in human neurons and glial cells","volume":"69","author":"Hatori","year":"2002","journal-title":"J Neurosci Res"},{"key":"key20180107214329_b40-or-29-02-0563","doi-asserted-by":"crossref","first-page":"11792","DOI":"10.1523\/JNEUROSCI.3588-08.2008","article-title":"Chemokine action in the nervous system","volume":"28","author":"Miller","year":"2008","journal-title":"J Neurosci"},{"key":"key20180107214329_b41-or-29-02-0563","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0006-8993(03)02867-1","article-title":"Production and neuroprotective functions of fractalkine in the central nervous system","volume":"979","author":"Mizuno","year":"2003","journal-title":"Brain Res"},{"key":"key20180107214329_b42-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.yexcr.2010.02.018","article-title":"CX3CR1 promotes recruitment of human glioma-infiltrating microglia\/macrophages (GIMs)","volume":"316","author":"Held-Feindt","year":"2010","journal-title":"Exp Cell Res"},{"key":"key20180107214329_b43-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2478(03)00101-9","article-title":"Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine\/CX3CL1","volume":"89","author":"Guo","year":"2003","journal-title":"Immunol Lett"},{"key":"key20180107214329_b44-or-29-02-0563","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ijc.10816","article-title":"Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells","volume":"103","author":"Guo","year":"2003","journal-title":"Int J Cancer"},{"key":"key20180107214329_b45-or-29-02-0563","first-page":"7468","article-title":"Fractalkine mediates natural killer-dependent antitumor responses in vivo","volume":"63","author":"Lavergne","year":"2003","journal-title":"Cancer Res"},{"key":"key20180107214329_b46-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.gt.3302959","article-title":"Gene therapy with CX3CL1\/Fractalkine induces antitumor immunity to regress effectively mouse hepatocellular carcinoma","volume":"14","author":"Tang","year":"2007","journal-title":"Gene Ther"},{"key":"key20180107214329_b47-or-29-02-0563","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jso.20642","article-title":"Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma","volume":"95","author":"Matsubara","year":"2007","journal-title":"J Surg Oncol"},{"key":"key20180107214329_b48-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.jid.5700751","article-title":"Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin","volume":"127","author":"Scholz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"key20180107214329_b49-or-29-02-0563","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2005.12.029","article-title":"CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement","volume":"397","author":"le Blanc","year":"2006","journal-title":"Neurosci Lett"},{"key":"key20180107214329_b50-or-29-02-0563","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1189\/jlb.1003465","article-title":"Cell surface-anchored SR-PSOX\/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells","volume":"75","author":"Shimaoka","year":"2004","journal-title":"J Leukoc Biol"},{"key":"key20180107214329_b51-or-29-02-0563","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4049\/jimmunol.176.1.43","article-title":"The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT","volume":"176","author":"Hase","year":"2006","journal-title":"J Immunol"},{"key":"key20180107214329_b52-or-29-02-0563","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells","volume":"181","author":"Matsumura","year":"2008","journal-title":"J Immunol"},{"key":"key20180107214329_b53-or-29-02-0563","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1349-7006.2008.00833.x","article-title":"CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells","volume":"99","author":"Hu","year":"2008","journal-title":"Cancer Sci"},{"key":"key20180107214329_b54-or-29-02-0563","first-page":"297","article-title":"Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma","volume":"33","author":"Wente","year":"2008","journal-title":"Int J Oncol"},{"key":"key20180107214329_b55-or-29-02-0563","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2249.2008.03745.x","article-title":"Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections","volume":"154","author":"Gaida","year":"2008","journal-title":"Clin Exp Immunol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2164\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T08:14:32Z","timestamp":1562400872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,3]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,3]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/or.2012.2164"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2164","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,3]]}}}